Terephthalic Acid → HCID 178483021, 화합물

HRID 2284219노트

반응식

HRID 2284219 반응식
[CH3:1][N:2]([CH3:13])[C:3]1[NH:4][C:5]2[CH:11]=[C:10]([NH2:12])[CH:9]=[CH:8][C:6]=2[N:7]=1.[C:14]([OH:25])(=O)[C:15]1[CH:23]=[CH:22][C:18]([C:19]([OH:21])=O)=[CH:17][CH:16]=1>>[CH3:1][N:2]([CH3:13])[C:3]1[NH:7][C:6]2[CH:8]=[CH:9][C:10]([NH:12][C:19](=[O:21])[C:18]3[CH:17]=[CH:16][C:15]([C:14]([NH:12][C:10]4[CH:9]=[CH:8][C:6]5[NH:7][C:3]([N:2]([CH3:1])[CH3:13])=[N:4][C:5]=5[CH:11]=4)=[O:25])=[CH:23][CH:22]=3)=[CH:11][C:5]=2[N:4]=1

참가 물질

3

실험 절차

Compound 435 was prepared according to the procedure similar to that described in Scheme V from 2-dimethylamino-5-aminobenzimidazole and terephthalic acid. [M+H]+ calcd for C26H26N8O2: 483.22; found: 483.02.

출처 및 근거

ORD 기록
ord-9bc02d4b43c741cda7d3fba01111c178
출처 데이터셋
uspto-grants-2015_09
특허 번호
US09144557B2

반응 노트

불러오는 중…